Clinical trial
Open Label Randomized Phase II, Multicentre, Pilot Study to Evaluate Safety and Efficacy of the Combination of Cetuximab and Concomitant-Boost Accelerated Radiotherapy Followed or Not by a Complementary Treatment With Cetuximab in Patients With Locally Advanced Oropharynx Squamous Cell Carcinoma.
NCT00251381 is registered in ClinicalTrials.gov with Trial Form Support S.L. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Open Label Randomized Phase II, Multicentre, Pilot Study to Evaluate Safety and Efficacy of the Combination of Cetuximab and Concomitant-Boost Accelerated Radiotherapy Followed or Not by a Complementary Treatment With Cetuximab in Patients With Locally Advanced Oropharynx Squamous Cell Carcinoma.
- Lead sponsor
- Trial Form Support S.L.
- Phase
- Phase 2
- Overall status
- Unknown status
- Start date
- November 30, 2005
- Completion date
- November 30, 2009
- Enrollment
- 90
- Sites
- 18
Conditions
As the registry lists them; a condition with its own page is linked.